Skip to main content
Premium Trial:

Request an Annual Quote

The NIH Isn't the Only Agency That Needs Some Padding

FDA Science and Mission at Risk, a report submitted by an independent advisory board, has released a "horrifying" analysis of why the FDA seems to be at least one weak link in a chain (read: NIH) of underfunded scientific government agencies. An article in USA Today, pointed out by Deepak Singh, says that the "long list of ailments" is caused by underfunding and an overburdened workforce. "In addition to advocating for increased funding, the report recommends that the FDA, among other things, invest in IT, centralize science programs, create new science directors and hire more high-quality talent," says the article.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.